Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps

• by Bo Wei, Weigang Gan, Jiaxin Li, Feng Wang, Jun Wang, Binbin Wang, Jiaoyu He, Feng Liu

• June 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

• by Kerri Miller

• January 15, 2026

• 3 min

Real-world efficacy of stapokibart for severe olfactory dysfunction: early and sustained improvement independent of baseline type 2 inflammation status and nasal polyp burden

• by Xiang-Ning Cheng, Liu-Qing Zhou, Yue Zhou, Sha-Zhou Li, Shan Chen, Qing Cheng, Li-Yue Li, Jian-Jun Chen, Tao Zhou

• June 11, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

• by Kathryn Wighton

• February 25, 2026

• 2 min